JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A3729 PJ34

Target: PARP

Summary: PARP-l inhibitor

≥50.9 mg/mL
A3735 Preladenant

Target: Adenosine A2A Receptors

Summary: Adenosine A2A receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥7.3 mg/mL
A3744 Quetiapine

Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor

Summary: Dopamine receptor antagonist

insoluble in H2O; ≥19.18 mg/mL
A3752 Reparixin
1 Citation

Target: CXCR

Summary: Inhibitor of CXCL8 receptor and CXCR1/CXCR2 activation

insoluble in H2O; ≥14.15 mg/mL
A3761 RG2833

Target: HDAC

Summary: Brain-penetrant HDAC inhibitor

insoluble in H2O; ≥16.95 mg/mL
A3762 RG7112
5 Citation

Target: MDM2

Summary: MDM2 inhibitor, first clinical

≥36.4 mg/mL
A3766 Rimonabant hydrochloride

Summary: CB1 receptor inverse agonist

insoluble in H2O; insoluble in EtOH; ≥20.05 mg/mL
A3785 Salinomycin

Target: Antibiotic

Summary: Polyether ionophore antibiotic;anti-cancer
A3808 SD-208

Summary: TGF-βR I kinase inhibitor

≥8.95 mg/mL
A3889 Trelagliptin succinate

Summary: DPP-4 inhibitor

≥53.1 mg/mL